AHL
ARVN icon

Abel Hall LLC’s Arvinas ARVN Stock Holding History

Abel Hall LLC’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,534
Closed -$125K – 825
2025
Q4 		$125K Buy
+10,534
New +$115K 0.03% 594

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Abel Hall LLC's ARVN Position: Q1 2026 in Review

Abel Hall LLC sold out of Arvinas (ARVN) in Q1 2026, closing a stake of 10,534 shares — an estimated $125K sold.

Abel Hall LLC first reported a position in ARVN in Q4 2025 and held it in 1 quarter. The position peaked at $125K in Q4 2025. 207 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

  • Abel Hall LLC reported no remaining Arvinas position as of Q1 2026 after selling out during the quarter.
  • Abel Hall LLC sold 10,534 Arvinas shares in Q1 2026, an estimated $125K.
  • Abel Hall LLC first reported a position in Arvinas in Q4 2025 and held it in 1 quarter.
  • Abel Hall LLC's Arvinas position peaked at $125K in Q4 2025.
  • 207 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.